Table 2.
The clinical outcome according to serum P values (ng/ml) on ET day
| Variables* | Q1 (< 19 ng/ml) (n = 64) |
Q2 (19–29 ng/ml) (n = 65) |
Q3 (29–49 ng/ml) (n = 65) |
Q4 (> 49 ng/ml) (n = 64) |
P-value |
|---|---|---|---|---|---|
| Women’ age (yr.) | 31.8 ± 3.7 | 32.8 ± 4.4 | 33.4 ± 4.2 | 33.5 ± 3.8 | 0.066 |
| Body mass index (kg/m2) | 25.5 ± 2.1 | 24.8 ± 2.0 | 25.0 ± 2.1 | 24.8 ± 2.1 | 0.17 |
| Positive pregnancy rate/ET, n (%) | 31 (48.4) | 34 (52.3) | 27 (41.5) | 17 (26.6) | 0.017 |
| Blighted ovum rates/ET, n (%) | 2 (3.1) | 3 (4.6) | 7 (10.8) | 5 (7.8) | 0.301 |
| Clinical pregnancy rate/ET, n (%) | 29 (45.3) | 31 (47.7) | 20 (30.8) | 12 (18.8) | 0.002 |
| Miscarriage rate/ET, n (%) | 2 (6.89) | 1 (3.22) | 0 (0) | 1 (8.33) | 0.590 |
| Live birth rate/ET, n (%) | 27 (42.2) | 30 (46.2) | 20 (30.8) | 11 (17.2) | 0.002 |
* Significant level was considered at p < 0.05